Activity value 69papua new guinea Buyer,Last transaction date:
2021-04-03
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for lae pathology clnic from 2020 to 2021.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2021, the company has completed 31 transactions, with a transaction quantity of 68848 and a transaction weight of 0.
1wellona pharma
indiasupplier,they trade on 2021-04-03
587100%
>
Products
Total 262
ProductsTransactionsPerDetail
bat 32265.18%>
tent 13527.33%>
tablet 6513.16%>
oct 479.51%>
injection 479.51%>
+View All
Hscode rank
Total 53
HSCode NameTransactionsPerDetail
HS 3004909927555.67%>
HS 30049069153.04%>
HS 30041030142.83%>
HS 21069099142.83%>
HS 38220090132.63%>
+View All
Trading Area
Total 1
AreaTransactionsPerDetail
india587100%>
Port statistics
Total 3
Port NameTransactionsPerDetail
lae39967.97%>
port moresby6410.9%>
morobe5910.05%>
lae pathology clnic is papua new guinea Buyer,
and primarily engages in the import and export business of products such as bat,tent,tablet.
According to the 52wmb.com global trade database, as of 2021-04-03, the company has completed 587 international trades,
with its main trading regions covering india etc.
The core products include HS30049099,HS30049069,HS30041030 etc,
often transported via lae,port port moresby, port morobe etc,
and its main trading partners are wellona pharma.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on lae pathology clnic is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.